FindTrial
Sign In

Comparison of postoperative patient-controlled intravenous analgesia (PCIA) with Sufentanil combined with non-steroidal drugs or dexmedetomidine: a retrospective study

Comparison of postoperative patient-controlled intravenous analgesia (PCIA) with Sufentanil combined with non-steroidal drugs or dexmedetomidine: a retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038200
Enrollment
Unknown
Registered
2020-09-13
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sufentanil combined with non-steroidal drugs:Nil
Sufentanil combined with dexmedetomidine:Nil

Sponsors

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Receive postoperative sufentanil-based intravenous patient-controlled analgesia; 2. ASA I-IV.

Exclusion criteria

Exclusion criteria: 1. Data entry error; 2. analgesic time less than 24 hours; 3. analgesic pump failure; 4. analgesic effect or side effects were not evaluated; 5. additional excipients were added to PCIA; 6. Insufficient patient information.

Design outcomes

Primary

MeasureTime frame
Analgesic effect 24 hours after surgery;Postoperative analgesic adverse reactions within 24 hours;—

Countries

China

Contacts

Public ContactHan Lin

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

nanlinhannansh@qq.com+86 15868710831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026